Cell Communities: Tissues, Stem Cells, and Cancer in Molecular Biology

Overview

  • Examines the organization of cells into tissues and organs within a multicellular organism.
  • Explores mechanisms governing tissue assembly and the role of the extracellular environment.
  • Considers various cells and their organization into diverse tissues, emphasizing cytoskeletal networks.
  • Investigates the extracellular matrix (ECM) and cell junctions in preserving tissue integrity.
  • Discusses the significance of stem cells in tissue renewal and disorders like cancer.

Tissue and Organ Organization

  • How Tissues Are Constructed
    • Cells combine to form tissues, which further organize to create organs.
    • Emphasis on the extracellular environment's contributions to structural organization.
  • Example of Kidney Cells
    • Cells stained with H & E stain highlighted in the extracellular matrix (ECM).
    • Demonstrates tissue types such as epithelial, connective, and muscle tissues.

Strengthening Mechanisms in Plant and Animal Tissues

  • Plant Tissues Strengthened by Cell Walls

    • Cell walls surround plant cells, composed of cellulose (blue) and pectin (green).
    • Provides mechanical support to withstand stress.
  • Animal Tissues Strengthened by ECM and Cytoskeleton

    • Connective tissue primarily consists of ECM, with fewer cells than other tissue types.
    • Examples include:
    • Rigid bone
    • Flexible tendons
    • Shock-absorbing cartilage
    • Jelly-like vitreous in the eye.
    • Connective tissues bear mechanical stress using cytoskeletal linkages.

Collagen and ECM in Animal Tissues

  • Role of Collagen in Connective Tissues

    • Major ECM proteins; collagens are fibrous proteins providing tensile strength.
    • Secreted by fibroblasts and osteoblasts, collagens account for 25% of total protein mass in mammals.
    • Characterized by a triple-helix structure rich in glycine and proline, with a Gly-X-Y amino acid repeat.
  • Collagen Synthesis and Assembly

    • Fibrillar collagens are synthesized in the rough endoplasmic reticulum (rER).
    • Procollagen is secreted and cleaved by proteases to form collagen fibrils (trimers).
  • Clinical Relevance

    • Defects in procollagen processing can lead to disease, characterized by reduced tensile strength and overstretchable connective tissues.
  • Diversity in Collagen Fiber Structures

    • Different tissues form various collagen networks (e.g., skin contains oriented bundles at 90-degree angles).
    • Tendons have parallel collagen fiber bundles, while other tissues may have a meshwork structure.

Cell Interaction with ECM

  • Common Properties of Cell Interaction with ECM

    • Cells can either immobilize (attach) or migrate on the ECM.
    • Surface receptors are required for attachment, primarily interacting with fibronectin.
  • Fibronectin and Integrins

    • Fibronectin is a protein dimer that binds cells to ECM proteins, including collagens.
    • Integrins act as transmembrane receptors connecting Fibronection with the actin cytoskeleton. They can be activated by binding to cytoskeletal proteins or ECM ligands.
  • Basal Lamina (Basement Membrane)

    • An essential ECM type for cell attachment in epithelial cells, using integrins to bind laminin proteins.

Clinical Relevance: Integrin Mutations

  • Mutations Impacting Integrins
    • Various integrins and associated diseases, including lethal impacts due to mutations.
    • Examples:
    • a5β1 (fibronectin): Ubiquitous, mutations lead to severe developmental defects.
    • α1β1 (laminin): Present in muscles, critical for muscle development.

Proteoglycans and GAGs in ECM

  • Importance of Proteoglycans
    • GAGs such as hyaluronan contribute to ECM structure and functionality, resisting compression.
    • Dense connective tissue has less GAG, while jelly-like ECM is enriched with proteoglycans.

Cancer and Stem Cells

  • Cancer as a Disease of Tissue Renewal

    • Disruption of tissue renewal processes leads to uncontrolled cell proliferation and cancer.
    • Characterization of tumors (benign vs malignant based on localized growth vs metastasis).
  • Stem Cells in Renewal

    • Adult stem cells are responsible for tissue repair and renewal, committing to specific cell types.
    • Example: Gut epithelium contains stem cells at the base of crypts, which proliferate and differentiate into specialized cells.

Clinical Applications of Stem Cells

  • Embryonic Stem Cells (ES Cells)

    • Pluripotent stem cells derived from embryos can differentiate into any cell type, offering potential organ regeneration therapies.
    • Issues with immune rejection must be addressed.
  • Somatic Cell Nuclear Transfer

    • A technique for producing ES cells using somatic cell nuclei implanted into enucleated eggs for therapeutic cloning.
  • Induced Pluripotent Stem (iPS) Cells

    • Generated from adult cells without destroying embryos, iPS cells hold promise for diverse clinical applications.

Cancer Development and Mechanisms

  • Accumulation of Mutations

    • Cancer arises through genetic mutations that may be spontaneous or induced by mutagens.
    • Genetic instability in cancer cells can lead to chromosomal anomalies.
  • Natural Selection in Tumor Evolution

    • Cancer cells undergo evolution, acquiring mutations that enhance survival and proliferation, resulting in selective advantages.
  • Key Genes in Cancer

    • Oncogenes: Activate mutations leading to increased cell growth and division (e.g., Ras).
    • Tumor Suppressor Genes: Loss-of-function mutations result in uncontrolled cell proliferation (e.g., p53, APC).
  • Pathway Impact on Cancer

    • Mutations affect critical pathways influencing cell proliferation, DNA repair, and survival.
    • Example of colorectal cancer illustrates mutation-driven tumor development.

Therapeutic Approaches in Cancer Treatment

  • Targeting Oncogenes and Gene Therapy
    • Immunotherapy and specific gene targeting (e.g., Gleevec for chronic myeloid leukemia) are effective treatments.
    • Genetic therapies, like engineered T cells targeting cancer cells, exemplify the integration of gene therapy with immunotherapy strategies.